The COVID-19 pandemic brought life-changing disruptions to people around the world and has turned the typical vaccine R&D process on its head. A combination of urgent need, unprecedented investments, and advances in genetic engineering has allowed what was once mere speculation to become not only our reality, but our future. With pandemic vaccines now launching […]

After the successful four editions of Bioprocessing of Cell therapies, coming up with 5th Annual of Bioprocessing of Biotherapeutics brings together leading bioprocessing scientists to share day-to-day challenges and practical solutions for the development, manufacture and quality of protein expressions, cell, and gene therapies. The virtual event will present detailed case studies and interactive discussions […]

As the therapeutic value of manipulating previously hard-to-drug ubiquitin ligases becomes more and more evident in addressing numerous diseases with unmet clinical needs, the inaugural Ligase Targeting Drug Development Summit arrives as the dedicated scientific and networking forum for large pharma, innovative biotech and research institutes to seize the day. Built with large pharma and […]

With clinical holds lifting there has been more investment and clinical progress in the gene therapy for muscular disorders space than ever before, yet the consequences of toxicity are not a distant memory. Despite the successes, there are still withstanding challenges for gene therapy developers targeting the muscle when it comes to optimizing delivery and […]

Harness the Maternal-Infant Microbiome, Establish New Mechanisms of Action, and Develop Breakthrough Health Products that Proactively Prevent Disease Risk Returning for another year, this platform will unite industry and academics in the exploration of preventative and therapeutic treatment of the microbiome during pregnancy and early life. The discussion during this 3-day conference will cover key […]

This is the definitive drug development forum for research teams to investigate how to modulate the cGAS-STING and Toll-like receptor (7/8/9) pathways both as monotherapies and as adjuvants in combinatorial approaches. This meeting comes at a critical point for the cancer immunotherapy field, as researchers look to increase patient response rates and the efficacy on checkpoint inhibitors in several […]

In the context of unprecedented gene therapy investment and clinical progress, with mounting regulatory scrutiny, Gene Therapy Analytical Development Europe will unite innovative biotech and pharma organisations to develop robust analytical tools to guarantee the consistency, quality, and safety of gene therapy products. Whether you’re looking for specific characterisation, potency or infectivity approaches to improve your current analytical toolbox or if […]

Hearing loss has a huge impact on the quality of life for millions of people, and as the average age of the population increases, the need for curative life-changing therapies targeting hearing loss and inner ear disorders has never been more important. The Inner Ear Disorders Therapeutics Summit is gathering the world’s leading biopharmaceutical companies […]

The TCR-based Therapies Summit is Dedicated to Supercharging TCR Design, Translation & Manufacturing Strategy for Solid Tumor Success Running digitally for 2021, the 2nd TCR-based Therapies Summit is the leading industry-focused meeting dedicated to supercharging the expanded TCR repertoire through enhanced target specificity, density & binding affinity for solid tumor indications. This June (8-10), join this exclusive community […]

The inaugural Next Generation Gene Therapy Vectors meeting is dedicated to overcoming the current immunogenicity, toxicity and manufacturability challenges facing the field by pioneering the next generation of superior delivery vectors. Industry pioneers from cutting edge biotechs and world-leading academic vectorology groups including Dyno Therapeutics, 4D Molecular Therapeutics and Generation Bio will share how ever-increasing clinical experience is guiding strategies to decrease […]

With commitments to advancing your preclinical and translational oncology research, we are delighted to bring the 9th annual PREDiCT: Tumor Models Cell Therapy Summit to your screens in July. See best-in-class tumor models and how they can be effectively utilized to model the tumor microenvironment and further your MoA understanding for new cell therapies. Learn to improve […]

SMi are proud to announce the 5th annual conference: Pre-Filled Syringes West Coast 2020 14-15 June 2021 San Diego, CA, USA Hyatt Regency Mission Bay www.prefilled-syringes-westcoast.com/pjwl Assessing Device Development and Regulation for Advanced Innovation SMi is proud to present the 5th Annual Pre-Filled Syringes West Coast Conference in San Diego on 14th and 15th June […]

As investments and collaborations hit a record high, the RNAi therapeutics industry continues to rapidly expand. With RNAi drugs prevailing as a therapy with huge potential against liver diseases, exciting efforts have now turned to a wide range of other diseases, from CNS, oncology, metabolism and more. Despite the growing momentum, much needs to be […]

Skin microbiome products have been gaining more momentum in the last few years with more brands starting to develop products, and personal care giants either starting to develop their own product or investing in start-ups focusing on these. It is a very exciting time for companies looking into this at the moment, figuring out not only product […]

SMi’s 4th Pharmaceutical Microbiology West Coast Conference Novel approaches and best practices for tackling current industry contamination control challenges SMi’s 4th Annual Conference Pharmaceutical Microbiology West Coast NEW DATE: June 17 – 18, 2021 Location: Hyatt Regency Mission Bay Hotel, San Diego, CA, USA Website: http://www.pharma-microbiology-usa.com SPONSORED BY: Associates of Cape Cod, bioMérieux, Bioscience International, Microcoat, Millipore […]

In its most exciting year yet the field of oncolytic virotherapy has seen the highest number of clinical read-outs, the emergence of next generation viruses, and never-before-seen combination therapies. Now in its 6th year, the Oncolytic Virotherapy Summit is the industry’s definitive guide to turning viral vehicles into clinically effective therapeutics across oncology indications. With 3 […]

Welcome to the Digital HER2-Targeted Therapies Summit 2021 - The First Conference Focused on Exploring New Frontiers of HER2 as a Pan-Tumor Target HER2 expressing patients are experiencing drug resistance, suboptimal duration of response and refractory/relapsed disease, stimulating new frontiers for HER2-targeted drug development. Impressive clinical data are being reported for next-generation anti-HER2 approaches in […]

CPhI & P-MEC China has launched the “E-Trade Season 2021” from March to June 2021 to provide the pharmaceutical industry with online learning and trading opportunities. One of the themed sessions, named Sino-India Pharmaceutical Exchange, will be focusing on Indian & Chinese pharma markets, with online learning and trading opportunities. The live stream webinar will […]

Now in its 3rd year, the Blood-Brain Barrier Summit is the industry’s definitive blood-brain barrier conference, focused exclusively on evaluating innovative approaches to tackling the single biggest challenge for CNS drug developers. Building on the success of last year’s meeting, this year’s program will uncover how leading companies and academics are working to enhance BBB penetration through the […]

Close the Clinical Gap, Discover the Next Generation of Microbiome-based Therapeutics, and Establish New Partnerships to Accelerate Your Research The advancing scientific and clinical landscape mixed with the high-quality audience that we bring together has made this the must attend conference for those translating microbiome science into clinically successful therapeutics. There is increased excitement around […]

Since the start of the 20th century, there have been three major waves of innovation in drug discovery. We are now at the start of a fourth wave, multispecific medicines, that will pave the way for new treatments aimed at thousands of disease targets currently viewed as “undruggable”. By inducing proximity between two or more proteins, multispecifics can […]

Returning to the digital stage this summer, the 2nd JAK Inhibitors Drug Development Summit brings you the only dedicated JAK inhibitor conference that will allow you to utilize the knowledge of the greatest minds and thought leaders within the realms of the JAK pathway across dermatology, rheumatology, gastroenterology, oncology and hematology. Focusing on optimized selectivity, […]

The 3rd Annual Cell Engager Summit is the only industry-led forum dedicated to developing multi-specific cell engaging therapies in liquid and solid tumor indications, accelerating early discovery innovation into the clinic. This forum comes at a critical point for the cell engager field as the success observed in the hematological field has not been obtained with solid […]

The inaugural ARDS Drug Development Summit will bring 60+ biopharma leaders together to discover how the rise of SARS-CoV-2 ARDS, emergence of novel targets, and the past 12 months of unprecedented global focus on ARDS research has transformed this graveyard of drug development failures into a starting point for the next generation of therapeutics addressing […]

The mRNA-Based Therapeutics Summit will unite the world leaders developing mRNA therapeutics to discuss learnings, challenges and future directions concerning translation and manufacturing of your novel mRNA modality. From mRNA vaccine development for infectious disease and oncology, effective mRNA gene therapies and novel delivery strategies, we bring to you an all-inclusive platform dedicated to accelerating successful translation of mRNA into a […]

The Non-Small Cell Lung Cancer (NSCLC) Drug Development Summit is the definitive industry-led forum for drug development in the largest solid tumor indication. This is a strategic conference designed to bring drug development teams together to address critical challenges surrounding therapeutic potency, tumor resistance and relapse and expanding the clinical utility of targeted and immuno-therapies, either in combination or […]

Develop & implement your practical roadmap to migrate your GxP regulated applications to the cloud with regulatory, security & partner selection guidance.  Establish robust documentation practices to maintain CFR 11 compliance, accurately assess data security risks for migrating to cloud infrastructure & select the right partner to ensure sustained continuous compliance. Nothing is more important […]

Returning digitally in 2021, the 2nd Annual Gene Therapy for Neurological Disorders Europe meeting will possibly be your last chance to attend a European meeting without the airmiles! Focusing on the industry’s challenges of developing and delivering gene therapies to the CNS and bringing fresh faces and emerging companies into the conversation, this is not one to miss […]

In-House Impact: Life Sciences is a new type of forum, designed for and by legal leaders in the Life Sciences, to help legal teams move from enterprise defenders to enablers of innovation and cross-functional competency. This conference isn’t just unique in offering an industry-specific platform for the most progressive legal leaders to maximize their own business value; it’s […]

In the fight against emerging coronavirus variants, the need for long-lasting immunity is greater than ever… which is why the field is looking beyond antibodies and turning to T cells. The Cell-Mediated Therapies for Infectious Disease Summit is the first industry-dedicated meeting to understand and stimulate the immune cell response to develop long term immune memory to […]